drugset / Trial / NCT01602692

A Comparison of Tumescence in Breast Reduction Surgery

NCT01602692 ↗

Phase 4 Completed 40 enrolled University of Wisconsin, Madison
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The investigators' main hypothesis is that in breast reduction surgery, the use of tumescent solution containing both dilute lidocaine and epinephrine will lead to better control of postoperative pain, nausea, vomiting, shorter time through postoperative phases of care, quicker discharge from the hospital and lower numbers of hospital readmissions than the use of tumescent solution containing only dilute epinephrine.

Timeline

Start
2012-08
Primary completion
2014-07
Completion
2014-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 0.05 % Other
Comparator Epinephrine Other / unclassified 1 ppm Other

Indications

No indication recorded.